Every 10-Q that LiveRamp Holdings, Inc. (RAMP) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow RAMP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RAMP filings page.
LiveRamp Holdings, Inc. reported solid growth and sharply higher profitability for the quarter ended December 31, 2025. Quarterly revenue rose to $212.2 million from $195.4 million, driven by both subscription and marketplace services, with gross margin steady at 71.9%.
Operating income increased to $39.5 million from $14.7 million as operating expenses fell 10%, helped by lower stock-based compensation and amortization. Net earnings from continuing operations climbed to $39.9 million, or $0.62 diluted EPS, compared with $9.5 million, or $0.14 diluted EPS, a year earlier.
For the nine months, revenue reached $606.8 million and net earnings from continuing operations were $75.0 million, versus $3.8 million in the prior-year period. LiveRamp ended the quarter with $395.9 million in cash and cash equivalents, continued to generate strong operating cash flow, and repurchased 4.3 million shares for $118.8 million year-to-date under its authorized buyback program.
LiveRamp (RAMP) reported stronger quarterly results. For the three months ended September 30, 2025, revenue was $199.8 million, up from $185.5 million a year ago. Income from operations rose to $21.4 million from $7.5 million, and net earnings increased to $27.4 million, with diluted EPS of $0.42 versus $0.03. For the six months, revenue reached $394.7 million compared to $361.4 million, and net earnings were $35.2 million, reversing a prior-year loss.
Gross profit for the quarter was $140.2 million. Operating expenses declined year over year, led by lower research and development and sales and marketing costs. Cash and cash equivalents were $369.4 million as of September 30, 2025. Remaining performance obligations were $651.7 million, with $429.9 million expected to be recognized over the next twelve months. During the six months, the company repurchased 2.9 million shares for $79.6 million, leaving $176.6 million of capacity under its $1.3 billion authorization. The number of common shares outstanding was 63,648,844 as of October 31, 2025.